4502 — Takeda Pharmaceutical Share News
0.000.00%
Last trade - 00:00US FDA approves Takeda's sleep disorder pill (updated)
US FDA approves Takeda's sleep disorder pill
Takeda Pharmaceutical Co Ltd reports results for the quarter ended June 30 - Earnings Summary
Table: Takeda Pharma -Q1 group results (IFRS)
China's Innocare says psoriasis oral drug shows 'consistent treatment effect' in late-stage trial (updated)
AI shortens drug discovery to around 1 year in China, Insilico CEO says
Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India (updated)
Takeda's QDENGA becomes first dengue vaccine approved in India
Brief: Takeda Pharmaceutical's Qdenga (Tak-003) Becomes First Dengue Vaccine To Be Approved In India- Statement
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Takeda And Indonesian Government Announce Landmark Collaboration To Strengthen Healthcare Resilience And Expand Access To Lifesaving Plasma-Derived Medicinal Products
Press Digest: Wall Street Journal - July 2
Brief: Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up To $600 Million - WSJ
Brief: Takeda Says Zasocitinib Significantly Outperforms Deucravacitinib In Head-To-Head Phase 3 Psoriasis Study
Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial
Brief: U.S. FDA Accepts Takeda's Application For Intravenous Entyvio® (Vedolizumab) In Pediatric Ulcerative Colitis And Crohn's Disease
Recorded 402.5 Billion Yen Additional Provision For Legal Proceedings After U.S. Jury Verdict In Antitrust Litigation
Table: Takeda Pharma -2025/26 group results (IFRS)
Table: Takeda Pharma -2025/26 parent results